Contact Information

160 Robinson Rd, #14-04
Sit Rd, SBF Center, Singapore 068914, a healthtech startup in India concentrating on diabetes management, has secured an additional US$5 million in its series A funding round, led by B Capital. This extension brings the total funding of the series A round to US$16 million.

  • Investors: Notable investors in this round include B Capital, established by Facebook co-founder Eduardo Saverin, along with previous backers such as MassMutual Ventures, Tanglin Venture Partners, and Endiya Partners.
  • Company Background: Founded in 2021, offers a subscription-based program for diabetes reversal, combining technology with personalized interventions.
  • Market Context: India faces significant diabetes challenges, with approximately 77 million adults living with Type 2 diabetes, according to the World Health Organization. Karan Mohla, general partner at B Capital, highlighted India’s dual disease burden and the persistent challenges of access, affordability, and quality in healthcare.
  • Future Plans: intends to utilize the newly secured funds to enhance brand presence and strengthen research and development efforts.

This funding extension underscores’s commitment to addressing the growing diabetes epidemic in India through innovative technological solutions and personalized care approaches.

client banner image

Leave a Reply

Your email address will not be published. Required fields are marked *